Search

Issue
Title
Authors
Association between the levels of serum vitamin D and trace elements and joint health in children with hemophilia
Mahmoud A.A., Sharaf A.E., Bayomy N.R., Abdel Nour B.S., Mahmoud A.A.
Clinical features and treatment of hemophilia B
Zozulya N.I., Andreeva T.A., Zharkov P.A., Vdovin V.V.
The prophylaxis of severe hemophilia A with inhibitors in children in the Republic of Belarus: a 12-year experience
Dmitriev E.V., Volkova L.I., Aleinikova О.V., Liubushkin A.V.
Pseudotumor of the maxilla as first presentation of hemophilia B in a 1-year-old male
Kalinina M.P., Pshonkin A.V., Grachev N.S., Poletaev A.V., Fedorova D.V., Zharkov P.A.
Treatment of severe hemophilia A without an inhibitor with emicizumab: 128 a case report
Andreyeva N.N., Korolyova D.N., Bogatyryova E.N., Sergeyeva A.A., Penkina N.I.
Description of health related quality of life of children and adolescents with hemophilia from India
Dsouza A., Nayak D., Kurien A., Pai M.S., Nayak B.S.
The retrospective study of cost-effectiveness for prophylactic and on-demand treatment of the pediatric patients with hemophilia A in Iran
Alidoust T., Bahadoram M., Alghasi A., Mahmoudian-Sani M., Akade E., Nilsaz-Dezfouli H., Keikhaei B.
The clinical use and cost-effectiveness of domestic blood coagulation factors VIII and IX
Fokina D.S., Zhukova O.V., Khokhlov A.L., Kudlay D.A., Borozinets A.Y., Pilyus F.G.
Bleeding rate reduction in children with hemophilia A and inhibitors treated with emicizumab in the real-world clinical setting
Zharkov P.А., Voronin K.A., Andreeva T.A., Asekretova T.V., Belkina Y.E., Demikhov V.G., Zinina E.E., Kolyasina T.A., Lebedev V.V., Markova I.V., Osmulskaya N.S., Petrov V.Y., Skobin V.B., Spichak O.V., Shelekhova T.V., Sherstnev D.G.
Secondary prevention of hemorrhagic complications and pharmacokinetics of factor VIII in children with severe hemophilia A
Dmitriev V.V., Volkova L.I., Dmitriev E.V.
CIC-rearranged sarcoma mimicking pseudotumor in a patient with hemophilia A
Artemov A.Y., Sinichenkova K.Y., Vorochay A.M., Pаnferova A.V., Sidorov I.V., Konovalov D.M., Grachev N.S., Bolshakov N.A., Druy A.E.
Risk factors for coagulation inhibitor development in children with severe hemophilia A
Dmitriev E.V., Liubushkin A.V.
Russian recombinant coagulation factors: the technological background and the results of clinical studies
Volkova S.A., Kudlay D.A., Bogomolova M.D., Sirotkin E.A., Sorokina Y.A.
Experience gained in the use of Coagyl-VII and evaluation of its hemostatic activity in a patient with inhibitory hemophilia A, receiving the drug in the home treatment setting after total knee arthroplasty
Volkova S.A.
Modern aspects of hemophilia A diagnosis
Poletaev A.V., Seregina E.A., Zharkov P.A.
Molecular genetic diagnosis in the group of hemophilia A patients in Belarus: 12 new allelic variants in the F8 gene
Liubushkin A.V., Guryanova I.E., Dmitriev E.V., Vertelko V.R., Polyakova E.A., Volkova L.I., Aleinikova O.V.
Transperitoneal hernioplasty in a patient with severe hemophilia A on preventive treatment with emicizumab
Shutov S.A., Danishyan K.I., Shcherbakova O.V., Gorgidze L.A., Batrov P.A., Dimitrieva O.S.
Efficacy and safety of Innonafactor in on-demand treatment of patients with severe and moderate hemophilia B: Results of part 2 of phase II-III clinical trial
Davydkin L.I., Zorenko V.Y., Andreeva T.A., Konstantinova V.N., Zalepukhina O.E., Klimova N.I., Mishin G.V., Krechetova A.V., Kurtov I.V., Shamina M.S., Fatenkova E.S., Gusyakova O.A., Shuster A.M., Kudlai D.A., Lukyanov S.V., Borozinets A.Y.
Efficiency and safety of Innonafactor in prevention of bleeding episodes in patients with severe and moderate hemophilia B: Results of part 1 of phase II-III clinical trial
Andreeva T.A., Zorenko V.Y., Davydkin I.L., Konstantinova V.N., Zalepukhina O.E., Klimova N.I., Mishin G.V., Krechetova A.V., Kurtov I.V., Shamina M.S., Fatenkova E.S., Gusyakova O.A., Shuster A.M., Kudlai D.A., Lukyanov S.V., Borozinets A.Y.
Statistically significant improvement in hemophilia A control: a retrospective analysis of the effectiveness and safety of emicizumab in children with severe and inhibitor forms of hemophilia A
Petrov V.Y., Lavrentyeva I.N., Vdovin V.V., Svirin P.V.
Laparoscopic appendectomy in a child with hemophilia A with inhibitors receiving prophylactic treatment with emicizumab
Lavrentyeva I.N., Vdovin V.V., Petrov V.Y., Mordvin P.A., Shevchenko T.V., Kopylov I.Y., Tiganova O.A., Kumirova E.V., Kozlov M.Y.
New approaches to the diagnosis and treatment of coagulation disorders
Shibeko A.M., Balandina A.N., Panteleev M.A.
Pharmacokinetic parameters of simoctocog alfa in children with hemophilia A without inhibitors in real clinical practice
Zharkov P.A., Florinskiy D.B., Shiller E.E.
Modern approaches in hemophilia therapy
Florinskiy D.B., Zharkov P.A.
The use of emicizumab in children with hemophilia A without inhibitors in the real-world clinical setting
Zharkov P.A., Voronin K.A., Florinskiy D.B., Andreeva T.A., Batdiyeva D.B., Goroshkova M.Y., Ignatyev S.V., Kreining V.V., Medova K.Y., Osmulskaya N.S., Petrov V.Y., Plaksina O.I., Shiller E.E., Elgakaeva K.M.
Immune tolerance induction with a high-purity von Willebrand factor containing plasma-derived factor VIII concentrate in a child with hemophilia A with inhibitors
Zharkov P.A., Fedorova D.V., Erega E.P., Poletaev A.V., Seregina E.A., Pshonkin A.V.
Use of the product Octophactor for prevention-treatment of patients with hemophilia A
Voitsekhovsky V.V., Esenina T.V., Filatova E.A., Mishkurova K.M., Fedorova N.A.
1 - 27 of 27 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"